Two of the most notable examples of this in recent years are Actavis (now owner of Allergan and to take Allergan's name globally) and Gilead. Actavis was a generics giant whose rise mirrors the ...
It is still saddled with a high level of debt that accompanied its takeover of Actavis, albeit reduced from a high of $34 billion to a current level of around $19 billion. It is also facing ...
A greater proportion of women in the intervention group reported tolerable pain during placement and expressed a willingness ...
The luxury gin brand has teamed up with the Italian shoe company on its first apparel collection, inspired by the brands' ...
Global Adrenogenital Syndrome Treatment MarketThe global Adrenogenital Syndrome Treatment Market is expected to achieve significant growth, reaching a market value of USD 12.81 billion in 2023. With a ...
HTSUFHisamitsu Pharmaceutical Co., Inc. Mayne Pharma Group Limited, a specialty pharmaceutical company, manufactures and sells branded and generic pharmaceutical products in Australia, New Zealand ...
To sign up for Becker's GI & Endoscopy E-Newsletter or any of our other E-Newsletters, click here. If you are experiencing difficulty receiving our newsletters, you may need to whitelist our new ...
Michael L. Krychman, MD; Jan L. Shifren, MD, NCMP; James H. Liu, MD; Sheryl L. Kingsberg, PhD; Wulf H. Utian, MB BCh, PhD, DSc(Med), FRCOG, FACOG, FICS ...
PREVIEW is an eight-issue subscription publication that provides expert, plain-language analysis of all cases given plenary review by the Supreme Court in advance of oral argument. Preview issues 1-7 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback